| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 10 | 11 | |
| 2005 | Abnormal liver function associated with occupational exposure to dimethylformamide and glutathione S-transferase polymorphisms | Luo J.-C.; TSUN-JEN CHENG ; Kuo H.-W.; Chang M.J.W. | Biomarkers | 30 | 29 |  |
| 2020 | Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan | YU-JEN FANG ; Chen M.-J.; CHIEH-CHANG CHEN ; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; MING-SHIANG WU ; Luo J.-C.; JYH-MING LIOU | Journal of the Formosan Medical Association | 11 | 8 | |
| 2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 5 | |
| 2016 | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; YU-JEN FANG ; CHIEH-CHANG CHEN ; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE ; Chen M.-J.; CHIEH-CHANG CHEN ; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hu W.-H.; YEN-NIEN CHEN ; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | The Lancet | 98 | 95 | |
| 2004 | Decreased Lung Function Associated with Occupational Exposure to Epichlorohydrin and the Modification Effects of Glutathione S-Transferase Polymorphisms | Luo J.-C.; TSUN-JEN CHENG ; Kuo H.-W.; Chang M.J.W. | Journal of Occupational and Environmental Medicine | 4 | 6 | |
| 2015 | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria | YU-JEN FANG ; JYH-MING LIOU ; CHIEH-CHANG CHEN ; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; PING-HUEI TSENG ; CHIEN-CHUAN CHEN ; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG ; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | Gut | 62 | 49 | |
| 2002 | Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers | Lei Y.-C.; Hwang S.-J.; Chang C.-C.; Kuo H.-W.; Luo J.-C.; Chang M.J.W.; TSUN-JEN CHENG | Mutation Research - Genetic Toxicology and Environmental Mutagenesis | 100 | 90 | |
| 2018 | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection | Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; WEN-FENG HSU ; Chang C.-C.; Lin J.-T.; CHIA-TUNG SHUN ; El-Omar E.M.; MING-SHIANG WU ; Liou J.-M.; YI-CHIA LEE ; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; CHIEH-CHANG CHEN ; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; TSU-YAO CHENG ; PING-HUEI TSENG ; HAN-MO CHIU ; Chang C.-C.; Yu C.-C.; Chiu M.-C.; YEN-NIEN CHEN ; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gastroenterology | 52 | 41 | |
| 1999 | Exposure to epichlorohydrin and dimethylformamide, glutathione S- transferases and sister chromatid exchange frequencies in peripheral lymphocytes | TSUN-JEN CHENG ; Hwang S.-J.; Kuo H.-W.; Luo J.-C.; Chang M.J.W. | Archives of Toxicology | 27 | 22 | |
| 2017 | Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials | Chen M.-J.; MING-SHIANG WU ; CHIEN-CHUAN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; WEN-FENG HSU ; Luo J.-C.; Lin J.-T.; JYH-MING LIOU ; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 18 | 15 | |
| 2018 | The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus | Cheng H.-C.; JYH-MING LIOU ; Luo J.-C.; Chiu C.-T.; MING-SHIANG WU ; YI-CHIA LEE ; Wu C.-Y.; Wu D.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Sheu B.-S. | Helicobacter | 1 | 1 | |
| 2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; Chen M.-J.; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 36 | 34 | |
| 2002 | Molecular biomarkers and epidemiologic risk assessment | Brandt-Rauf P.W.; Luo J.-C.; TSUN-JEN CHENG ; CHUNG-LI DU ; Wang J.-D.; Rosal R.; Do T.; Marion M.-J. | Human and Ecological Risk Assessment | 4 | 3 | |
| 2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 62 | 63 | |
| 2003 | Pulmonary function abnormality and respiratory tract irritation symptoms in epichlorohydrin-exposed workers in Taiwan | Luo J.-C.; Kuo H.-W.; TSUN-JEN CHENG ; Chang M.J.W. | American Journal of Industrial Medicine | 7 | 6 | |
| 2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; Chen M.-J.; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 58 | 57 | |
| 1993 | Serum c-erbB-2 oncopeptide in hepatocellular carcinogenesis | Luo J.-C.; MING-WHEI YU ; Chen C.-J.; Santella R.M.; Carney W.P.; Brandt-Rauf P.W. | Medical Science Research | 19 |
